Next Article in Journal
Impact of 4th of July Fireworks on Spatiotemporal PM2.5 Concentrations in California Based on the PurpleAir Sensor Network: Implications for Policy and Environmental Justice
Next Article in Special Issue
Novice Nurses’ Experiences Caring for Acutely Ill Patients during a Pandemic
Previous Article in Journal
Impact of COVID-19 on Pediatric Primary Care Visits at Four Academic Institutions in the Carolinas
Previous Article in Special Issue
Healthcare Provider Attitudes toward the Newly Developed COVID-19 Vaccine: Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Risk of Anxiety and/or Depression during Confinement Due to COVID-19 in Central Spain

1
Nursing Department, Faculty of Nursing, University of Valladolid, 47005 Valladolid, Spain
2
Nursing Care Research (GICE), Faculty of Nursing, University of Valladolid, 47005 Valladolid, Spain
3
Emergencies Management (SACYL), 40002 Segovia, Spain
4
Primary Care Management Valladolid West (SACYL), 47012 Valladolid, Spain
5
Primary Care Management Valladolid East (SACYL), 47010 Valladolid, Spain
6
General Hospital of Segovia (SACYL), 40002 Segovia, Spain
7
Faculty of Health Sciences, University of Castilla-La Mancha, 45600 Talavera de la Reina, Spain
8
Department of Biochemistry and Molecular Biology and Physiology, University of Valladolid, 47005 Valladolid, Spain
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(11), 5732; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115732
Submission received: 20 April 2021 / Revised: 20 May 2021 / Accepted: 25 May 2021 / Published: 27 May 2021
(This article belongs to the Special Issue Nursing and COVID-19 )

Abstract

:
(1) Background: The confinement of the population in response to the COVID-19 pandemic was related to an increased risk of suffering from anxiety and/or depression in previous studies with other populations. (2) Methods: descriptive study using surveys (Goldberg Anxiety and Depression Scale) with 808 participants over 18 years of age between 14 and 20 of May 2020 during the confinement due to the SARS-CoV-2 virus in Spain. (3) Results: 63% of the participants were at risk of suffering from anxiety and 64.9% were at risk of depression. Variables reaching statistical significance were: age (t anxiety = −0.139 and t depression = −0.153), gender (t anxiety = −4.152 and t depression = −4.178), marital status (anxiety F = 2.893 and depression F = 3.011), symptoms compatible with COVID-19 (t anxiety = −4.177 and t depression = −3.791), previous need for psychological help (t anxiety = −5.385 and t depression = −7.136) and need for such help at the time of the study (t anxiety = −9.144 and depression = −10.995). In addition, we generated two regression models that estimate the risk of anxiety and depression. (4) Conclusions: more than half of the participants were at risk of suffering from anxiety and/or depression, confirming the negative effect of confinement on the population.

1. Introduction

The pandemic produced by the SARS-CoV-2 virus has generated a global emergency, which has led to a series of measures that have included the confinement of the population in Spain and other countries [1,2].
On 31 December 2019, the WHO received a statement from the Chinese authorities of several cases of atypical pneumonia in the city of Wuhan [2,3]. A week later, this disease was termed COVID-19 (coronavirus disease 2019) after it was discovered that it was caused by a new coronavirus [4]. Months later, the virus spread rapidly throughout the world, with Spain being one of the most affected countries [5]. For this reason, the Spanish Government published a Royal Decree 463/2020 [6] on March 14 in the Official State Gazette, declaring a state of alarm for the management of the health crisis caused by COVID-19. Among other measures, the decree obliged the population to confine themselves to their homes from 15 March to 3 May 2020 [7]. This restriction of freedom of movement with the aim of controlling viral transmission was maintained at the time of the study, despite the relaxation of some of these restrictions. It was not until the publication of Order SND/380/2020, of 30 April, that the confinement measures were somewhat relaxed for the population over 14 years of age to allow outdoor sports [8]. Therefore, the Spanish population had remained strictly isolated in their homes for a little less than two consecutive months.
Although containment measures were necessary to control the outbreak, the possible consequences that confinement may have on the mental health of the population are still worrying [9,10,11]. Even the WHO recommended that the impact of confinement on people be quickly assessed to implement timely health measures that mitigate its harmful effects [12]. No similar situation has existed in Europe in recent years, but preliminary studies provide evidence of the deterioration of mental health in the population due to confinement. In China, two studies show higher rates of anxiety, depression, alcohol consumption and a lower proportion of mental well-being than usual in the population during the pandemic [13,14]. A study in India, with 1000 respondents with the Depression Anxiety Stress Scales (DASS21) questionnaire, presents significant differences between depression, anxiety and stress according to age, gender and employment [15]. In addition, in Italy, the mental health of the population has been affected and yet there have been fewer hospital admissions for psychological causes [16,17]. In the United Kingdom, research has been conducted that predicts anxiety and depression as a function of the presence of low income or loss of income and pre-existing health conditions in self and others [18]. Similarly in Denmark, higher rates of anxiety and depression due to confinement have also been found [19]. In Spain, the geographical area most affected by COVID-19 disease has been the center of the country [20], however, there is not previous research specifically investigating the mental health of the confined population in this region.
According to the prevalence of anxiety and depression in the aforementioned studies, we propose as working hypothesis that the confinement of the population of Spain was related to a greater risk of anxiety and/or depression. Hence, the objective of this study was to determine the risk of suffering from anxiety and/or depression in the Spanish population confined to regions of central Spain due to COVID-19.

2. Materials and Methods

2.1. Study Design

This is a descriptive study with a survey methodology carried out on a confined population. The data were collected from 14 to 20 May 2020. At that moment, the population had been confined to their homes for two months and de-escalation in Phase 0 had begun throughout Spain.
The study included persons residing in the central region of Spain during confinement, over 18 years of age, Spanish-speaking, with sufficient technical skills to answer an online survey and who voluntarily consented to participate in the study. We excluded Spaniards residing in other geographic areas than the central part of the country, those under 18 years of age, individuals who do not speak Spanish, those who don´t have the ability to handle online questionnaires and those who checked the refusal box in the study participation, even though they had completed the questionnaire.

2.2. Population and Ethical Aspects

We included the entire population over 18 years of age residing in central regions of Spain during the state of alarm due to SARS-CoV-2, who voluntarily accepted participation in the study on the indicated dates. A sample of 808 people who met the inclusion criteria was obtained.
The study was approved by the Ethics Committee for Drug Research of the Valladolid East health area, with registration code PI 20-1803 NO HCUV on 14 May 2020. This study conforms to the STROBE Initiative (Strengthening the Reporting of Observational Studies in Epidemiology) for observational studies of the EQUATOR Initiative [21].

2.3. Outcome Measures

The study variables we aimed to describe and correlate were: age, gender, marital status, being a health worker, place of confinement, number of confined people in the home, having been dismissed from work, suffering from COVID-19 symptoms (fever, headache, dry cough, sore throat, dyspnea, nausea and vomiting, diarrhea, fatigue, ageusia, and anosmia) [16], undergoing COVID-19 diagnostic tests (rapid antigen detection test or viral RNA detection by RT-PCR), a family member or friend who suffered from COVID-19, previous need for mental healthcare, current need for mental healthcare, being at risk of suffering from anxiety and/or depression.

2.4. Data Collection

Due to the conditions at the time of study, sampling was non-probabilistic through volunteering and secondarily by chain referral to obtain the largest possible sample. Recruitment was carried out through social networks (WhatsApp®, Facebook® and Twitter®), in which the link to the questionnaire was disseminated through Google Forms® on Google Drive®.
For data collection, we used a self-administered and anonymous questionnaire in which all the aforementioned variables were collected, using the Goldberg Anxiety and Depression Scale (GADS) [22,23] (Appendix A; Table A1). This screening tool measures the possibility of suffering from anxiety and/or depression. It consists of two subscales with nine items each, whose answers are dichotomous in a Yes/No format, and in which one point is assigned to an affirmative answer and 0 to a negative answer. The first four items of each of the subscales determine the risk of suffering from anxiety (in 4 points) and/or depression (in ≥2 points). Higher scores in each subscale are related to a higher risk, but the total score of the instrument (anxiety score and depression score) is not meaningful and generally not used, unless the first items show alteration. The anxiety scale has a sensitivity of 82% and the depression scale with 85%. The positive predictive value for anxiety is 0.56 and for depression 0.85 [22].

2.5. Data Analysis

We used descriptive analysis with measures of sample distribution (frequencies and percentages), centrality (mean) and dispersion (standard deviation [SD]) of the variables. Quantitative variables were analyzed using a normality test (Kolmogorov–Smirnov), using parametric tests (ANOVA, Student’s t-test and Pearson’s correlation coefficient) for the inferential analysis of the results and the total scores of the anxiety and depression subscales.
In an attempt to search for predictive models of factors related to anxiety and depression, we decided to use a Bayesian probability model. A multiple regression analysis was done in successive steps, from which predictive models with significant variables (p ≤ 0.01) and model equations were obtained, both for anxiety and depression. For data analysis, we used IBM SPSS Statistics, version 24.0 (SPSS Inc., Chicago, IL, USA). In all tests, a confidence level of 95% and a p-value below 0.05 were considered significant.

3. Results

3.1. Descriptive Data

In total, 808 participants were included, who were between 18 and 80 years old, with a mean of 43.4 years (95% CI: 42.7–44.0, SD 19.0). The vast majority resided in the Autonomous Community of Castilla y León (76.6%); only 85 (10.5%) participants lived alone. The average number of cohabitants in a household was 2.35 (95% CI: 1.9–2.8, SD 1.3). Most participants had kept their jobs, had not been infected with COVID-19, had not presented compatible symptoms or required diagnostic tests. Regarding the need for psychological and psychiatric help, 244 people (30.2%) had needed it at some point in their life, while at the time of study, 10.8% were in need. 31.4% believed that confinement was negatively affecting cohabitation in their homes (Table 1).
Table 2 shows the results of the anxiety and depression subscales in the GADS. To verify the reliability of the results, Crombach’s α was calculated at 0.859 for the total scale (18 items), and at 0.793 and 0.776 for the anxiety (nine items) and depression (nine items) subscales, respectively, which confers validity to the results.
Considering the cutoff number of the first four items of each subscale, 63% (509) of the sample was at risk of suffering from anxiety (4 points in the first four items of the anxiety subscale) and 64.9% (524) were at risk of depression (≥2 in the first four items of the depression subscale) (Table 3). The mean anxiety subscale score was 4.72, (95% CI 3.78–5.66, SD 1.43); while in the depression subscale, the mean of responses was 3.34 (95% CI 2.46–4.22, SD 1.36).

3.2. Inferential Analysis

We performed parametric tests after verifying the normal distribution of the total scores on the anxiety and depression subscales to determine the relationship between sociodemographic variables, COVID-19-related variables, and the results of the GADS questionnaire subscales (Table 4).
In relation to age, the Pearson correlation coefficient was −0.139 for anxiety and −0.153 for depression, both weakly statistically significant (p = 0.01 bilateral). It is shown that at an older age the risk of suffering from anxiety and depression decreases. Concerning gender differences, we compared means with the Student’s t test, obtaining the value t = −4.152 (p = 0.000) in anxiety, and a value t = −4.178 (p = 0.000) in depression. Both anxiety and depression symptoms were much more frequent in women.
Among the variables that showed significant results in both anxiety and depression scores, we identified the marital status of the participants (ANOVA anxiety F = 2.893; p = 0.002 and ANOVA depression F = 3.011; p = 0.002), having had symptoms compatible with COVID-19 (t anxiety = −4.177; p = 0.000 and t depression = −3.791; p = 0.000) and cohabitation (ANOVA anxiety F = 13.636; p = 0.000 and ANOVA depression F = 10.007; p = 0.000). Nonetheless, the number of cohabitants did not reach statistical significance according to Pearson’s correlation coefficient, 0.044 for anxiety and 0.027 for depression (p = 0.01 bilateral).
In contrast, the variables that did not show a statistically significant relationship were: the geographical place of residence (anxiety ANOVA: F = 0.934; p = 0.495 and depression ANOVA: F = 1.220; p = 0.279), health profession (anxiety t = −1.694; p = 0.091; and t depression = −1.651; p = 0.099), job dismissal (t anxiety = −1.554; p = 0.121 and t depression = −1.546; p = 0.123) and having been diagnosed with SARS-CoV-2 infection (t anxiety = 0.104; p = 0.917 and t depression = 0.010; p = 0.992).
Having undergone diagnostic tests for COVID-19 had no statistical significance for anxiety (t = −1.226; p = 0.221), but it did for depression (t = −2.324; p = 0.020). However, having a family member or friend who had suffered from SARS-CoV-2 produced statistically significant differences in anxiety (t = −2.183; p = 0.029), but not in depression (t = −1.851; p = 0.065).
Finally, subjects who previously required psychological or psychiatric care were more likely to suffer from anxiety (t = −5.385; p = 0.000) and depression (t = −7.136; p = 0.000). Similar results were obtained if such help was needed at the time of the study (t anxiety = −9.144; p = 0.000 and t depression = −10.995; p = 0.000).

3.3. Regression Analysis

We did a successive step multiple linear regression analysis to determine which variables played a more important role in producing anxiety and depression symptoms (p < 0.01) (Table 5).
Total anxiety score = 10.226 + (1400 × cohabitation) − (0.03 × age) + (1.394 × COVID symptoms)
Theorem 1.
The variables ‘living with someone during confinement’, ‘age’ and ‘presenting symptoms of COVID infection’ increase the score on the anxiety subscale of the GADS instrument and therefore the subjective perception of suffering from anxiety. The results determine a predictor model of anxiety (R2 = 0.245).
Total depression score = 11.221 (−0.046 × age) + (1.281 × cohabitation)
Theorem 2.
The variables ‘age’ and ‘living with someone during confinement’ increase the score on the depression subscale of the GADS instrument and therefore the subjective perception of suffering from depression, with a predictive model of depression (R2 = 0.289).

4. Discussion

Taking into account the research findings, the working hypothesis can be partially accepted, since the factors age, gender, marital status, suffering from symptoms compatible with COVID-19 and requiring previous or current psychological care, were related to having an increased risk of anxiety and/or depression. Having undergone a diagnostic test for SARS-CoV-2 increased the risk of depression whereas having a family member or friend sick with COVID-19 increased the risk of anxiety.
Based on the results, it seems logical to say that confinement has had a negative effect on the population of central Spanish areas, which has been at risk of suffering from symptoms of anxiety and depression, results comparable with other studies carried out in Spain [3,5] and other countries [13,14,15,16,17,18,19].
It is surprising that unemployment was not identified as an essential factor for either depression or anxiety, since it is usually related to symptoms thereof in other studies [5,7,15,18,24]. The reason for this result is unknown, however, it may be related to participants responding more positively to a temporary dismissal that resulted from a reversible adjustment of employment levels due to the pandemic. Similarly, ample scientific literature describes the risk of suffering from anxiety and depression in the health professions [1,7,25]. In both cases, the low representation of these groups in the sample may have influenced the results. The economic influence of the pandemic should be carefully monitored by public organizations to support financially and psychologically numerous self-employed professions [26].
The low rates of positive COVID-19 diagnoses are consistent with epidemiological data published by the Ministry of Health, according to which around 5% of the population had developed antibodies to SARS-CoV-2 at the time of study [27]. The frequency of symptoms compatible with SARS-CoV-2 was higher than the percentage of positive diagnostic tests, probably, as other authors point out, because these symptoms are sometimes nonspecific, as is the case with fever, dry cough, and gastrointestinal symptoms [28].
Unsurprisingly, having required psychological help previously or at the time of study was related to the presence of anxious–depressive symptoms. However, some participants had had professional help at some point in their life but not during the pandemic. The cause of this effect is unknown, and it should be studied in depth in future research, since it contradicts the existing literature [17,29,30].
That younger people are at greater risk of anxiety and depression than older people was not surprising, coinciding with Ahmeda et al. [14]. Age was the variable that most influenced the presence of anxious–depressive symptoms together with gender, as corroborated by other studies [13,15,18,19]. In China, the most affected age range is 21 to 40 years [14]. In India, 15 to 35 years of age [15]. In the United Kingdom, early ages are the most affected [18] and in Denmark the middle ages [19].
Having to undergo a diagnostic test for COVID-19 increases the risk of depression. This result agrees with that of Chinese researchers who related it to mechanisms of anticipation of suffering the disease [31]. In addition, having a close person diagnosed as COVID-19-positive was related to anxiety, as also pointed out by Inchausti et al. [7] and Alamri et al. [32].
Living with at least two people has been considered an advantage since it may provide emotional support [18], but not all the scientific literature agrees on this point. Some studies highlight the need for a space of solitude within your own home, which is more complicated if you live with someone [23,33]. Jimenez et al. agree on quality of cohabitation and age were found to be key variables in the psychological impact of confinement [34]. Our results show that, during confinement, the number of cohabitants was not relevant for the development of anxiety or depression. However, cohabitation in general was relevant, as it constituted a risk factor for suffering from anxiety and depression. Marital status was another variable that had an influence on presenting anxious–depressive symptoms, and is related to cohabitation. Some research has revealed a greater perceived social support by people who have a partner, which seems of utmost importance during confinement [18,23].
Finally, it should be noted that the study provides a reality that, in the early stages of the pandemic, when the absolute priority was the lives of people, was not taken into account. Although some authors have published studies on this subject [34], in the case of Spain there is not much research and even less in our population group belonging to the central region of the country. The findings of this research show the possibility of suffering from anxiety and depression in a situation of home confinement and justify the creation of health programs to prevent this alteration of psychological health, as well as early detection, follow-up and treatment of the problems generated by isolation in the home in the face of an illness that entails major changes in living and working habits. Certain skills such as self-efficacy and the possibility that increasing self-compassion may be used to promote better mental health in similar situations [35,36,37].

Limitations

We encountered difficulties during the study due to the circumstances associated with its design, which is why we might have incurred a selection bias in the participants due to a non-randomized sample. We assumed this bias due to the impossibility of accessing a large sample volume in such short period of time with other sampling methods. Due to the time required for approval by the ethics committee and the different rates of de-escalation in the different autonomous communities, most of the sample came from Castilla y León and Madrid, which impedes generalizing the results to the entire country. This sampling, however, strengthens the homogeneity of our data since both regions were still in Phase 0 of the de-escalation on the dates of study. Based on these issues, we propose to obtain a representative sample of the national population in the future. In addition, the use of a Likert scale questionnaire may generate response biases such as social desirability and acquiescence response [38,39], validation data can help quantify or mitigate this issue [40,41].

5. Conclusions

This study aimed to assess the risk of anxiety and/or depression during confinement due to the COVID-19 pandemic in the Spanish population. We found that 63% of the sample was at risk of suffering from anxiety and 64.9% at risk of depression.
The factors age, gender, marital status, suffering from symptoms compatible with COVID-19 and needing previous or current psychological help, were related to a greater risk of anxiety and/or depression. The risk of anxiety was fundamentally related to cohabitation, age and presenting symptoms compatible with COVID-19, while the risk of depression was mainly related to cohabitation and age.
In conclusion, taking care of the mental health of the population is essential in situations of confinement due to a pandemic. This requires developing action plans that allow an immediate response in the event of a further wave of SARS-CoV-2 or pandemics caused by other infectious agents.

Author Contributions

Conceptualization, R.M.C.-G. and I.C.-G.; methodology, E.O.; software, C.D.-F.; validation, L.P.P., V.N.M. and R.M.C.-G.; formal analysis, R.M.C.-G.; investigation, I.C.-G.; resources, L.P.P.; data curation, E.O.; writing—original draft preparation, R.M.C.-G.; writing—review and editing, C.D.-F.; visualization, I.C.-G.; supervision, R.M.C.-G.; project administration, R.M.C.-G.; funding acquisition, V.N.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee for Drug Research of the Valladolid East Health Area (PI 20-1803 NO HCUV on 14 May 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Appendix A

Table A1. Self-administered questionnaire.
Table A1. Self-administered questionnaire.
1. Age
2. Sex
- Male
- Female
- Other
3. Relationship status
- Married
- Cohabitation
- Separated/Divorced
- Widower/Widow
- Single
4. Are you a Health worker?
- Yes
- No
5. Where are you confined?
- Castile and León
- Madrid
- Other
6. How many people, including you, are living confined at home?
- Just me
- 2
- 3
- 4
- More than 4
7. Do you have a job dismissal due to COVID-19?
- Yes
- No
8. Do you have been diagnosed with COVID-19?
- Yes
- No
10. Do you have been tested for COVID-19?
- Yes
- No
11. Do you have had any symptoms compatible with COVID-19?
- Yes
- No
12. Do you have anyone in your family or friends diagnosed with COVID-19?
- Yes
- No
13. Do you have ever needed psychological or psychiatric help?
- Yes
- No
14. Are you needing psychological or psychiatric help these days?
- Yes
- No
15. Do you think that confinement is negatively affecting your coexistence?
- Yes
- No
16. Regarding the last week of confinement (Goldberg Anxiety and Depression Scale) *
* Participants answered 18 anxiety and depression-related questions from the Goldberg Anxiety and Depression Scale (GADS), which are copyrighted and cannot be disseminated without permission from the authors who created and validated the questionnaire for this purpose.

References

  1. Ibáñez-Vizosó, J.E.; Alberdi-Páaramo, I.; Díaz-Marsá, M. International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic. Rev. Psiquiatr. Salud Ment. 2020, 13, 111–113. [Google Scholar]
  2. Fernández-Riquelme, S. Primera Historia de la crisis del Coronavirus en España. La Razón Histórica Rev. Hispanoam. Hist. Ideas Políticas Soc. 2020, 46, 12–22. [Google Scholar]
  3. Ozamiz-Etxebarria, N.; Dosil-Santamaria, M.; Picaza-Gorrochategui, M.; Idoiaga-Mondragon, N. Niveles de estrés, ansiedad y depresión en la primera fase del brote del COVID-19 en una muestra recogida en el norte de España. Cad. Saúde Pública 2020, 36, e00054020. [Google Scholar] [CrossRef] [PubMed]
  4. Cruz, M.P.; Santos, E.; Cervantes, M.V.; Juárez, M.L. COVID-19, una emergencia de salud pública mundial. Rev. Clínica Española 2021, 221, 55–61. [Google Scholar] [CrossRef]
  5. Sandín, B.; Valiente, R.M.; García-Escalera, J.; Chorot, P. Psychological impact of the COVID-19 pandemic: Negative and positive effects in Spanish people during the mandatory national quarantine. Rev. Psicopatología Psicol. Clínica 2020, 25, 1–22. [Google Scholar] [CrossRef]
  6. Real Decreto 463/2020. Boletín Oficial del Estado, n° 67, 14 de Marzo de 2020. pp. 25390–25400. Available online: https://www.boe.es/eli/es/rd/2020/03/14/463 (accessed on 20 April 2021).
  7. Inchausti, F.; García-Poveda, N.V.; Prado-Abril, J.; Sánchez-Reales, S. La Psicología Clínica ante la Pandemia COVID-19 en España. Clínica Salud 2020, 31, 105–107. [Google Scholar] [CrossRef]
  8. Orden SND/380/2020. Boletín Oficial del Estado, n° 121, 30 de Abril de 2020. pp. 30925–30929. Available online: https://www.boe.es/eli/es/o/2020/04/30/snd380/con (accessed on 20 April 2021).
  9. Urzúa, A.; Vera-Villarroel, P.; Caqueo-Urízar, A.; Polanco-Carrasco, R. La Psicología en la prevención y manejo del COVID-19. Aportes desde la evidencia inicial. Rev. Int. Psicol. Ter. Psicol. 2020, 38, 103–118. [Google Scholar]
  10. Ramírez-Ortiz, J.; Castro-Quintero, D.; Lerma-Córdoba, C.; Yela-Ceballos, F.; Escobar-Córdoba, F. Mental health consequences of the COVID-19 pandemic associated with social isolation. Colomb. J. Anesthesiol. 2020, 48, e930. [Google Scholar] [CrossRef]
  11. Qiu, J.; Shen, B.; Zhao, M.; Wang, Z.; Xie, B.; Xu, Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen. Psychiatry 2020, 33, e100213. [Google Scholar] [CrossRef] [Green Version]
  12. Tricco, A.C.; Langlois, E.V.; Straus, S.E. Rapid Reviews to Strengthen Health Policy and Systems: A Practical Guide; World Health Organization: Geneva, Switzerland, 2017; Available online: https://www.who.int/alliance-hpsr/resources/publications/rapid-review-guide/en/ (accessed on 20 April 2021).
  13. Meng, H.; Xu, Y.; Dai, J.; Zhang, Y.; Liu, B.; Yang, H. Analyze the psychological impact of COVID-19 among the elderly population in China and make corresponding suggestions. Psychiatry Res. 2020, 289, 112983. [Google Scholar] [CrossRef]
  14. Ahmed, M.Z.; Ahmed, O.; Zhou, A.; Sang, H.; Liu, S.; Ahmad, A. Epidemic of COVID-19 in China and associated Psychological Problems. Asian J. Psychiatry 2020, 51, 102092. [Google Scholar] [CrossRef]
  15. Husain-Kazmi, S.S.; Hasan, K.; Talib, S.; Saxena, S. COVID-19 and Lockdown: A study on the Impact on Mental Health 19. SRNN 2020, 1–13. [Google Scholar] [CrossRef]
  16. Girardi, P. COVID-19: An Epidemiological Perspective. Ph.D. Thesis, Dipartimento di Psicologia dello Sviluppo e della Socia-lizzazione Universita‘ degli Studi di Padova, Padova, Italy, 2020. [Google Scholar]
  17. Clerici, M.; Durbano, F.; Spinogatti, F.; Vita, A.; De Girolamo, G.; Micciolo, R. Psychiatric hospitalization rates in Italy before and during COVID-19: Did they change? An analysis of register data. Ir. J. Psychol. Med. 2020, 37, 283–290. [Google Scholar] [CrossRef] [PubMed]
  18. Shevlin, M.; McBride, O.; Murphy, J.; Miller, J.G.; Hartman, T.K.; Levita, L.; Mason, L.; Martinez, A.P.; McKay, R.; Stocks, T.V.A.; et al. Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19 pandemic. BJPsych Open 2020, 6, e125. [Google Scholar] [CrossRef] [PubMed]
  19. Sønderskov, K.M.; Dinesen, P.T.; Santini, Z.I.; Østergaard, S.D. The depressive state of Denmark during the COVID-19 pandemic. Acta Neuropsychiatr. 2020, 32, 226–228. [Google Scholar] [CrossRef] [Green Version]
  20. Pollán, M.; Pérez-Gómez, B.; Pastor-Barriuso, R.; Oteo, J.; Hernán, M.A.; Pérez-Olmeda, M.; Sanmartín, J.L.; Fernández-García, A.; Cruz, I.; de Larrea, N.F.; et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study. Lancet 2020, 396, 535–544. [Google Scholar] [CrossRef]
  21. Vandenbroucke, J.P.; Von Elm, E.; Altman, D.G.; Gøtzsche, P.C.; Mulrow, C.D.; Pocock, S.J.; Poole, C.; Schlesselman, J.J.; Egger, M. Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration. Gac. Sanit. 2009, 23, 158.e1–158.e28. [Google Scholar] [CrossRef]
  22. Goldberg, D.; Bridges, K.; Duncan-Jones, P.; Grayson, D. Detecting anxiety and depression in general medical settings. In BMJ; 1988; Volume 297, pp. 897–899. [Google Scholar] [CrossRef] [Green Version]
  23. Montón, C.; Pérez-Echevarría, M.J.; Campos, R. Escalas de ansiedad y depresión de Goldberg: Una guía de entrevista eficaz para la detección del malestar psíquico. Aten. Primaria 1993, 12, 345–349. [Google Scholar]
  24. García-Hernández, A.M. Duelo y confinamiento. Rev. Ene Enfermería 2020, 14, 1–7. [Google Scholar]
  25. Sher, L. COVID-19, anxiety, sleep disturbances and suicide. Sleep Med. 2020, 70, 124. [Google Scholar] [CrossRef]
  26. Dalewski, B.; Palka, L.; Kiczmer, P.; Sobolewska, E. The Impact of SARS-CoV-2 Outbreak on the Polish Dental Community’s Standards of Care—A Six-Month Retrospective Survey-Based Study. Int. J. Environ. Res. Public Health 2021, 18, 1281. [Google Scholar] [CrossRef]
  27. Ministerio de Sanidad de España. Madrid. Available online: https://www.mscbs.gob.es/gabinete/notasPrensa.do?id=4950 (accessed on 20 April 2021).
  28. Becerra-García, J.A.; Giménez, G.; Sánchez-Gutiérrez, T.; Barbeito Resa, S.; Calvo Calvo, A. Síntomas psicopatológicos du-rante la cuarentena por COVID-19 en población general española: Un análisis preliminar en función de variables sociodemo-gráficas y ambientales-ocupacionales. Rev. Esp. Salud Publica 2020, 94, e1–e11. [Google Scholar]
  29. Vieta, E.; Pérez, V.; Arango, C. Psychiatry in the aftermath of COVID-19. Rev. Psiquiatr. Salud Ment. 2020, 13, 105–110. [Google Scholar] [CrossRef]
  30. Crespo-Facorro, B. Mental health and the SARS-CoV-2 pandemic. Rev. Psiquiatr. Salud Ment. 2020, 13, 55–56. [Google Scholar] [CrossRef] [PubMed]
  31. Liu, N.; Zhang, F.; Wei, C.; Jia, Y.; Shang, Z.; Sun, L.; Wu, L.; Sun, Z.; Zhou, Y.; Wang, Y.; et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter. Psychiatry Res. 2020, 287, 112921. [Google Scholar] [CrossRef] [PubMed]
  32. Alamri, H.S.; Algarni, A.; Shehata, S.F.; Al Bshabshe, A.; AlShehri, N.N.; AlAsiri, A.M.; Hussain, A.H.; Alalmay, A.Y.; AlShehri, E.A.; AlQarni, Y.; et al. Prevalence of Depression, Anxiety, and Stress among the General Population in Saudi Arabia during Covid-19 Pandemic. Int. J. Environ. Res. Public Health 2020, 17, 9183. [Google Scholar] [CrossRef]
  33. Pérez-Martínez, J.A. Diario de un mes de confinamiento (12 de marzo de 2020–15 de abril de 2020). La Razón Histórica 2020, 46, 32–38. [Google Scholar]
  34. Jiménez, Ó.; Sánchez-Sánchez, L.C.; García-Montes, J.M. Psychological Impact of COVID-19 Confinement and Its Relationship with Meditation. Int. J. Environ. Res. Public Health 2020, 17, 6642. [Google Scholar] [CrossRef] [PubMed]
  35. Gutiérrez-Hernández, M.; Fanjul, L.; Díaz-Megolla, A.; Reyes-Hurtado, P.; Herrera-Rodríguez, J.; Enjuto-Castellanos, M.; Peñate, W. COVID-19 Lockdown and Mental Health in a Sample Population in Spain: The Role of Self-Compassion. Int. J. Environ. Res. Public Health 2021, 18, 2103. [Google Scholar] [CrossRef]
  36. Marle, C.J.-L.; Parmentier, F.; Vinchon, F.; Storme, M.; Borteyrou, X.; Lubart, T. Evolution and impact of self-efficacy during French COVID-19 confinement: A longitudinal study. J. Gen. Psychol. 2021, 148, 360–381. [Google Scholar] [CrossRef] [PubMed]
  37. Waters, L.; Algoe, S.B.; Dutton, J.; Emmons, R.; Fredrickson, B.L.; Heaphy, E.; Moskowitz, J.T.; Neff, K.; Niemiec, R.; Pury, C.; et al. Positive psychology in a pandemic: Buffering, bolstering, and building mental health. J. Posit. Psychol. 2021, 1–21. [Google Scholar] [CrossRef]
  38. Kreitchmann, R.S.; Abad, F.J.; Ponsoda, V.; Nieto, M.D.; Morillo, D. Controlling for Response Biases in Self-Report Scales: Forced-Choice vs. Psychometric Modeling of Likert Items. Front. Psychol. 2019, 10, 2309. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Morillo, D.; Abad, F.J.; Kreitchmann, R.S.; Leenen, I.; Hontangas, P.; Ponsoda, V. The Journey from Likert to Forced-Choice Questionnaires: Evidence of the Invariance of Item Parameters. Rev. Psicol. Trab. Organ. 2019, 35, 75–83. [Google Scholar] [CrossRef] [Green Version]
  40. Bauhoff, S. Self-Report Bias in Estimating Cross-Sectional and Treatment Effects. In Encyclopedia of Quality of Life and Well-Being Research; Metzler, J.B., Ed.; Springer: Dodlerk, The Netherlands, 2014; pp. 5798–5800. [Google Scholar]
  41. Harpe, S.E. How to analyze Likert and other rating scale data. Curr. Pharm. Teach. Learn. 2015, 7, 836–850. [Google Scholar] [CrossRef]
Table 1. Frequency distribution and percentages of general variables (* N = 808), Spain, 2020.
Table 1. Frequency distribution and percentages of general variables (* N = 808), Spain, 2020.
VariablesValues:
Frequency (N)/Percentage (%)
Gender
Male158 (19.6)
Female650 (80.4)
Age (years)
<40325 (40.2)
40–49221 (27.4)
50–59151 (18.7)
>60111 (13.7)
Marital status
Married354 (43.8)
Partnered73 (9.0)
Separated or divorced63 (7.8)
Single306 (37.9)
Widowed12 (1.5)
Healthcare worker
Yes172 (21.3)
Autonomous community
Castilla y León619 (76.6)
Madrid85 (10.5)
Other104 (12.9)
Number of cohabitants
2270 (33.4)
3202 (25.0)
4203 (25.1)
More than 448 (5.9)
Lived alone85 (10.5)
Dismissal from work
Yes60 (7.4)
COVID-19 diagnostic
Yes30 (3.7)
Diagnostic COVID-19 test
Yes109 (13.5)
COVID-19 symptoms
Yes151 (18.7)
Family member or friend with COVID-19
Yes395 (48.9)
Previous psychological help
Yes244 (30.2)
Current psychological help
Yes87 (10.8)
Confinement in the household ( n = 727)
Yes254 (34.9)
* N—total number of participants in the sample;  n—number of participants that were evaluated.
Table 2. Affirmative responses in anxiety and depression subscales of the GADS * ( N = 808), Spain, 2020.
Table 2. Affirmative responses in anxiety and depression subscales of the GADS * ( N = 808), Spain, 2020.
Anxiety Subscale of the GADS *
Key SymptomValues:
Frequency (N)/Percentage (%)
Anguished and nervous402 (49.8)
Worried586 (72.5)
Irritable377 (46.7)
Difficulty relaxing435 (53.6)
Bad sleep quality472 (58.4)
Headache417 (41.6)
Tremor and/or tingling and/or dizziness and/or sweating and/or diarrhea201 (24.9)
Worried about health449 (55.6)
Difficulty falling asleep472 (58.4)
Depression Subscale of the GADS *
Key SymptomValues:
Frequency (N)/Percentage (%)
Low energy levels464 (57.4)
Loss of interest in things314 (38.9)
Loss of self-confidence163 (20.2)
Hopelessness188 (23.3)
Difficulties concentrating422 (42.2)
Weight loss150 (18.6)
Wakes up earlier than usual369 (45.7)
Slowness in carrying out activities383 (47.4)
Feeling worse in the morning244 (30.2)
* Goldberg Anxiety and Depression Scale; N—total number of participants in the sample.
Table 3. Prevalence of anxiety and depression symptoms according to GADS * (N = 808), Spain, 2020.
Table 3. Prevalence of anxiety and depression symptoms according to GADS * (N = 808), Spain, 2020.
VariablesFrequency
( n = 808)
Percentage
%
CI 95%
Symptoms of anxiety
Yes (=4)5096359.6–66.4
No (<4)2993733.6–40.4
Symptoms of depression
Yes (≥2)52464.961.5–68.1
No (<2)28435.131.8–38.4
* Goldberg Anxiety and Depression Scale;  n—number of participants that were evaluated.
Table 4. Inferential analysis between variables and scale GADS (N = 808), Spain, 2020.
Table 4. Inferential analysis between variables and scale GADS (N = 808), Spain, 2020.
VariablesPearson Correlation Coefficient (r)
AnxietyDepression
Age−0.139 *−0.153 *
Number of cohabitants0.0440.027
VariablesANOVA (F)
AnxietyDepression
Marital status2.893 **3.011 **
Cohabitation13.636 **10.007 **
Geographical place0.9341.220
VariablesStudent t-Test (t)
AnxietyDepression
Gender−4.152 **−4.178 **
COVID symptoms−4.177 **−3.791 **
Health profession−1.6941.651
Job dismissal−1.554−1.546
COVID diagnostic0.1040.010
COVID tests−1.226−2.324 *
COVID diagnostic of family member or friend−2.183 *−1.851
Psychological or psychiatric care (pre pandemic)−5.385 *−7.136 **
Psychological or psychiatric care (during pandemic)−9.144 **−10.995 **
* p < 0.05; ** p < 0.01; Goldberg Anxiety and Depression Scale.
Table 5. Models of regression analysis. Theorem 1 and Theorem 2 (N = 808), Spain, 2020.
Table 5. Models of regression analysis. Theorem 1 and Theorem 2 (N = 808), Spain, 2020.
FactorTheorem 1
BStandard ErrorβtpCI 95%
Constant10.2261.077 94970.0008.102–12.35
Cohabitation1.4000.3010.3224.6580.0000.807–1.003
Age−0.0330.010−0.225−3.2590.001−0.052–−0.013
COVID symptoms1.3940.4470.1973.1180.0020.512–2.275
FactorTheorem 2
BStandard ErrorβtpCI 95%
Constant11.2210.867 12.9440.0009.511–12.931
Age−0.0460.009−0.333−4.9680.000−0.064–−0.028
Cohabitation1.2810.2790.3084.6000.0000.732–1.830
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cárdaba-García, R.M.; Pérez Pérez, L.; Niño Martín, V.; Cárdaba-García, I.; Durantez-Fernández, C.; Olea, E. Evaluation of the Risk of Anxiety and/or Depression during Confinement Due to COVID-19 in Central Spain. Int. J. Environ. Res. Public Health 2021, 18, 5732. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115732

AMA Style

Cárdaba-García RM, Pérez Pérez L, Niño Martín V, Cárdaba-García I, Durantez-Fernández C, Olea E. Evaluation of the Risk of Anxiety and/or Depression during Confinement Due to COVID-19 in Central Spain. International Journal of Environmental Research and Public Health. 2021; 18(11):5732. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115732

Chicago/Turabian Style

Cárdaba-García, Rosa M, Lucia Pérez Pérez, Virtudes Niño Martín, Inés Cárdaba-García, Carlos Durantez-Fernández, and Elena Olea. 2021. "Evaluation of the Risk of Anxiety and/or Depression during Confinement Due to COVID-19 in Central Spain" International Journal of Environmental Research and Public Health 18, no. 11: 5732. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18115732

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop